Can I Take 5-HTP with Praluent (Alirocumab)?
Clinical review of 5-HTP and Praluent (alirocumab) together: interaction risk, serotonin concerns, dose-separation guidance, and monitoring for patients on PCSK9 inhibitors.
30 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.

Showing 30 of 30 clinical reviews.
Clinical review of 5-HTP and Praluent (alirocumab) together: interaction risk, serotonin concerns, dose-separation guidance, and monitoring for patients on PCSK9 inhibitors.
Clinical review of taking alpha-lipoic acid with Praluent (alirocumab). Covers interaction mechanisms, dose-separation windows, blood sugar monitoring, thyroid considerations, and what to do if you already take both.
A physician-reviewed guide to the ashwagandha and alirocumab interaction: mechanisms, evidence, monitoring parameters, and what to tell your cardiologist before combining them.
A physician-reviewed guide to combining berberine with Praluent (alirocumab). Learn what the pharmacokinetic data show, what risks exist, and how to monitor safely if you choose to take both.
Evidence-based review of caffeine and alirocumab (Praluent) interactions, covering pharmacokinetic and pharmacodynamic data, cardiovascular monitoring, and practical dosing guidance.
Evidence-based guide on combining calcium supplements with Praluent (alirocumab). Covers pharmacokinetic interactions, dose-separation windows, monitoring, and clinical recommendations.
A clinical guide to combining CoQ10 supplementation with alirocumab (Praluent), covering interaction mechanisms, safety data, dosing guidance, and monitoring recommendations from the HealthRX medical team.
A clinician-reviewed guide to taking creatine while on Praluent (alirocumab): pharmacokinetic safety, the creatinine lab artifact, monitoring protocols, and what to tell your prescriber.
A physician-reviewed guide to combining folate supplements with Praluent (alirocumab), covering pharmacokinetic safety, MTHFR considerations, homocysteine monitoring, and practical dosing advice.
A physician-reviewed guide on ginseng and Praluent (alirocumab) interactions, covering mechanism, safety, monitoring, and what to do if you take both.
A clinician-reviewed guide to combining glutathione supplements with alirocumab (Praluent), covering pharmacokinetics, interaction evidence, dosing timing, and monitoring protocols.
Evidence-based guide on taking glycine supplements with Praluent (alirocumab). Covers interaction risk, pharmacokinetic data, dose-separation, monitoring, and clinical guidance.
A clinician-reviewed guide covering the safety, pharmacokinetic profile, hepatotoxicity risk, and practical dosing guidance for combining green tea extract or EGCG with Praluent (alirocumab).
A clinically detailed look at whether L-theanine is safe to take alongside Praluent (alirocumab), covering pharmacokinetics, pharmacodynamics, current evidence, and practical guidance from the HealthRX medical team.
A physician-reviewed guide to the lion's mane and Praluent (alirocumab) interaction: mechanisms, safety evidence, monitoring, and when to call your cardiologist.
A clinician-reviewed guide on combining magnesium supplements with Praluent (alirocumab), covering interaction mechanisms, safety evidence, dosing timing, and monitoring recommendations.
Evidence-based guide on combining melatonin with Praluent (alirocumab). Covers interaction risk, pharmacokinetic and pharmacodynamic profiles, dose-separation guidance, monitoring, and clinical recommendations.
A clinician-reviewed guide to the NAC and Praluent (alirocumab) interaction, covering pharmacokinetics, pharmacodynamics, dosing, monitoring, and safety evidence for patients on PCSK9-inhibitor therapy.
Evidence-based guide on combining omega-3 fatty acids (EPA/DHA) with Praluent (alirocumab). Covers interaction mechanisms, safety data, dosing guidance, and monitoring recommendations.
A clinician-reviewed guide to the quercetin, alirocumab interaction: pharmacokinetics, CYP3A4 considerations, LDL monitoring, and practical dosing guidance for patients on Praluent.
Evidence-based guide on combining reishi mushroom supplements with Praluent (alirocumab). Covers interaction mechanisms, safety data, monitoring recommendations, and clinical guidance.
A clinician-reviewed guide to the resveratrol, alirocumab interaction: pharmacokinetics, safety, monitoring, and practical dosing advice for patients on Praluent.
A clinician-reviewed guide to the rhodiola and Praluent (alirocumab) interaction, covering pharmacokinetics, pharmacodynamics, serotonergic concerns, monitoring, and what to do if you are already taking both.
A physician-reviewed guide to the saw palmetto and Praluent (alirocumab) interaction, covering mechanisms, monitoring, and clinical decision-making for patients on PCSK9 inhibitor therapy.
A clinical review of the interaction between St. John's Wort and Praluent (alirocumab), covering mechanism, safety, monitoring, and what to do if you're already taking both.
A clinician-reviewed guide to the turmeric/curcumin and Praluent (alirocumab) interaction: what the evidence says, which risks are real, how to monitor, and what to tell your prescriber.
A complete clinical guide to combining vitamin B12 supplementation with Praluent (alirocumab): interaction risk, mechanism, monitoring, and dosing strategy reviewed by board-certified physicians.
Evidence-based guide on taking vitamin B6 with Praluent (alirocumab). Covers interaction risk, dosing, monitoring, and clinical recommendations for safe co-administration.
Evidence-based guide on combining vitamin D supplements with Praluent (alirocumab). Covers interaction risk, monitoring, dosing, and what to tell your prescriber.
A clinician-reviewed guide on taking zinc supplements alongside Praluent (alirocumab). Learn about interaction mechanisms, copper balance, monitoring, and safe use guidance backed by primary literature.